HOFBF
Price
$0.17
Change
+$0.01 (+6.25%)
Updated
Jul 7 closing price
Capitalization
75.6M
INNMF
Price
$0.20
Change
-$0.01 (-4.76%)
Updated
Jul 21 closing price
Capitalization
72.05M
Interact to see
Advertisement

HOFBF vs INNMF

Header iconHOFBF vs INNMF Comparison
Open Charts HOFBF vs INNMFBanner chart's image
Hofseth Biocare ASA
Price$0.17
Change+$0.01 (+6.25%)
Volume$10K
Capitalization75.6M
Amplia Therapeutics
Price$0.20
Change-$0.01 (-4.76%)
Volume$154.1K
Capitalization72.05M
HOFBF vs INNMF Comparison Chart in %
Loading...
HOFBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INNMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HOFBF vs. INNMF commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOFBF is a Hold and INNMF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2025
Stock price -- (HOFBF: $0.17 vs. INNMF: $0.20)
Brand notoriety: HOFBF and INNMF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HOFBF: 350% vs. INNMF: 260%
Market capitalization -- HOFBF: $75.6M vs. INNMF: $72.05M
HOFBF [@Biotechnology] is valued at $75.6M. INNMF’s [@Biotechnology] market capitalization is $72.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOFBF’s FA Score shows that 0 FA rating(s) are green whileINNMF’s FA Score has 0 green FA rating(s).

  • HOFBF’s FA Score: 0 green, 5 red.
  • INNMF’s FA Score: 0 green, 5 red.
According to our system of comparison, INNMF is a better buy in the long-term than HOFBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOFBF’s TA Score shows that 1 TA indicator(s) are bullish while INNMF’s TA Score has 4 bullish TA indicator(s).

  • HOFBF’s TA Score: 1 bullish, 1 bearish.
  • INNMF’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, HOFBF is a better buy in the short-term than INNMF.

Price Growth

HOFBF (@Biotechnology) experienced а 0.00% price change this week, while INNMF (@Biotechnology) price change was -9.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.39%. For the same industry, the average monthly price growth was +15.71%, and the average quarterly price growth was +33.77%.

Industries' Descriptions

@Biotechnology (+2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HOFBF($75.6M) and INNMF($72M) have the same market capitalization . INNMF YTD gains are higher at: 384.262 vs. HOFBF (66.600). INNMF has higher annual earnings (EBITDA): -6.43M vs. HOFBF (-73.54M). HOFBF has more cash in the bank: 71.9M vs. INNMF (10.9M). INNMF has less debt than HOFBF: INNMF (13.9K) vs HOFBF (236M).
HOFBFINNMFHOFBF / INNMF
Capitalization75.6M72M105%
EBITDA-73.54M-6.43M1,144%
Gain YTD66.600384.26217%
P/E RatioN/AN/A-
Revenue266MN/A-
Total Cash71.9M10.9M660%
Total Debt236M13.9K1,697,842%
FUNDAMENTALS RATINGS
HOFBF vs INNMF: Fundamental Ratings
HOFBF
INNMF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
52
Fair valued
PROFIT vs RISK RATING
1..100
10064
SMR RATING
1..100
9997
PRICE GROWTH RATING
1..100
4434
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INNMF's Valuation (52) in the null industry is somewhat better than the same rating for HOFBF (85). This means that INNMF’s stock grew somewhat faster than HOFBF’s over the last 12 months.

INNMF's Profit vs Risk Rating (64) in the null industry is somewhat better than the same rating for HOFBF (100). This means that INNMF’s stock grew somewhat faster than HOFBF’s over the last 12 months.

INNMF's SMR Rating (97) in the null industry is in the same range as HOFBF (99). This means that INNMF’s stock grew similarly to HOFBF’s over the last 12 months.

INNMF's Price Growth Rating (34) in the null industry is in the same range as HOFBF (44). This means that INNMF’s stock grew similarly to HOFBF’s over the last 12 months.

INNMF's P/E Growth Rating (100) in the null industry is in the same range as HOFBF (100). This means that INNMF’s stock grew similarly to HOFBF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HOFBFINNMF
RSI
ODDS (%)
N/A
Bearish Trend 5 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
33%
Bearish Trend 5 days ago
83%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bullish Trend 5 days ago
23%
Bearish Trend 5 days ago
64%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
14%
Bearish Trend 5 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
12%
Bullish Trend 5 days ago
73%
Advances
ODDS (%)
N/A
Bullish Trend 15 days ago
64%
Declines
ODDS (%)
N/A
Bearish Trend 9 days ago
70%
BollingerBands
ODDS (%)
N/A
Bearish Trend 5 days ago
89%
Aroon
ODDS (%)
N/A
Bullish Trend 5 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
HOFBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INNMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DSKIF24.83N/A
N/A
Daiseki Co., Ltd.
EZOO0.25N/A
N/A
EZAGOO LTD.
PSORF13.64N/A
N/A
Pearson PLC
SMAWF260.02-7.31
-2.74%
Siemens AG
RDUFF0.12-0.03
-20.00%
Radius Gold Inc.

HOFBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOFBF has been closely correlated with ACHV. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if HOFBF jumps, then ACHV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOFBF
1D Price
Change %
HOFBF100%
N/A
ACHV - HOFBF
72%
Closely correlated
-0.75%
COGT - HOFBF
63%
Loosely correlated
-1.52%
KROS - HOFBF
38%
Loosely correlated
+0.29%
XFOR - HOFBF
35%
Loosely correlated
+6.99%
UNBX - HOFBF
33%
Loosely correlated
N/A
More

INNMF and

Correlation & Price change

A.I.dvisor tells us that INNMF and CGEN have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INNMF and CGEN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INNMF
1D Price
Change %
INNMF100%
-4.76%
CGEN - INNMF
24%
Poorly correlated
-1.95%
HOFBF - INNMF
22%
Poorly correlated
N/A
EXEL - INNMF
21%
Poorly correlated
-0.47%
ARMP - INNMF
21%
Poorly correlated
-0.83%
KRRO - INNMF
20%
Poorly correlated
-2.41%
More